TeamViewer (TMV) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Feb, 2026Executive summary
FY 2025 was a transitional year with the integration of 1E, strong enterprise momentum, and a focus on revitalizing SMB and global sales, while AI integration and the launch of TeamViewer One became key differentiators.
Achieved FY 2025 pro forma revenue of €767.5m, up 5% year-over-year in constant currency, meeting guidance with growth across all regions.
Adjusted EBITDA grew 8% to €340.3m, with a margin of 44.3%, reflecting strong profitability and a 2 percentage point improvement over 2024.
Enterprise ARR grew 19% year-over-year in constant currency, with new ARR doubling and strategic wins in DEX and Frontline, including the largest-ever deal.
1E business saw a turnaround in Q4 2025, with sequential ARR growth and key DEX contract wins.
Financial highlights
FY 2025 pro forma revenue: €767.5m (+5% cc yoy); ARR: €759.7m (+2% cc yoy).
Adjusted EBITDA: €340.3m (+8% yoy); margin: 44.3% (+2pp yoy).
Adjusted basic EPS increased 17% year-over-year to €1.23.
Q4 2025 revenue: €194.6m; Q4 Adjusted EBITDA margin: 45%.
Adjusted levered free cash flow for 2025 was €208.3m, with a cash conversion rate of 61%.
Outlook and guidance
FY 2026 revenue growth is guided at 0–3% in constant currency, with adjusted EBITDA margin expected around 43%.
Net leverage ratio targeted to improve to around 2.3x by year-end 2026.
Midterm outlook anticipates a re-acceleration to mid- to high-single-digit growth, with ARR uptick expected in 2027 and revenue growth following.
Latest events from TeamViewer
- Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025